News

Article

University of Colorado Anschutz Medical Campus Ophthalmology Department receives $40 million gift

Key Takeaways

  • A $40 million donation to CU Anschutz Department of Ophthalmology will support eye disease research and treatment, focusing on macular degeneration and glaucoma.
  • The donation establishes a research endowment, accelerating innovation and technology translation from lab to patient care.
SHOW MORE

The gift will be used to treat and potentially cure eye diseases such as macular degeneration and glaucoma, increase focus on basic science, and harness artificial intelligence to revolutionize vision care.

(Image Credit: AdobeStock)

(Image Credit: AdobeStock)

The University of Colorado Anschutz Medical Campus’ Department of Ophthalmology has received a $40 million gift. The donor, a patient at the UCHealth Sue Anschutz-Rodgers Eye Center, has chosen to remain anonymous.

The Sue Anschutz-Rodgers Eye Center is the sole academic eye center in Colorado and serves about 115,000 patients a year.

The university stated that the gift will be used to treat and potentially cure eye diseases such as macular degeneration and glaucoma, increase focus on basic science, and harness artificial intelligence to revolutionize vision care.

Donald M. Elliman, CU Anschutz chancellor, commented on the donation in a press release from the university.

"This transformational gift was made possible by one of our longstanding philanthropic partners, whose family holds a deep passion for improving health and health care in Colorado and beyond," said Elliman. "Their generous investment has established the Department of Ophthalmology Research Endowment, which will provide resources to speed innovation and research with the potential to save and restore sight."

An undisclosed portion of the donation is available for immediate use by the university, while the rest will provide ongoing support well into the future.

CU Anschutz Department of Ophthalmology has won 60 patents since 2020, and at least 13 technologies have been invented and licensed to industry, such as the Kahook Dual Blade, designed for minimally invasive glaucoma surgery.

"We have a tremendous opportunity to fuel our research enterprise, which is fundamental to clinical care," said Naresh Mandava, MD, chair of the CU Department of Ophthalmology and the Sue Anschutz-Rodgers Endowed Chair in Retinal Diseases. "This gift will allow us to translate technology from the lab to the patient faster than before."

The Sue Anschutz-Rodgers Eye Center has previously launched the CellSight program, which is working to develop novel stem cell–based therapies to save and restore eyesight in patients with blinding diseases. Additionally, the University of Colorado Age-Related Macular Degeneration (AMD) registry allows researchers to investigate AMD, with nearly 2000 patients from the Sue Anschutz-Rodgers Eye Center enrolled.

Reference
Historic $40 million gift to CU Anschutz Dept of Ophthalmology will fuel research and new therapies. News release. University of Colorado Anschutz Medical Campus. June 3, 2025. Accessed June 9, 2025. https://www.prnewswire.com/news-releases/historic-40-million-gift-to-cu-anschutz-dept-of-ophthalmology-will-fuel-research-and-new-therapies-302472221.html

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.